US Stock MarketDetailed Quotes

Bristol-Myers Squibb (BMY)

Watchlist
  • 58.260
  • +0.480+0.83%
Close Apr 28 16:00 ET
  • 58.290
  • +0.030+0.05%
Post 20:01 ET
118.95BMarket Cap16.84P/E (TTM)

Bristol-Myers Squibb (BMY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-6.81%14.16B
-55.53%1.97B
12.88%6.31B
68.40%3.92B
-31.05%1.95B
9.60%15.19B
4.40%4.44B
17.68%5.59B
23.26%2.33B
-4.58%2.83B
Net income from continuing operations
178.98%7.06B
1,327.63%1.09B
80.66%2.2B
-22.03%1.31B
120.68%2.46B
-211.11%-8.93B
-95.69%76M
-37.18%1.22B
-18.92%1.68B
-625.28%-11.91B
Operating gains losses
-27.31%-1.45B
-525.00%-475M
-61.67%-485M
28.12%-271M
43.98%-214M
-56.77%-1.14B
74.50%-76M
-35.14%-300M
-128.48%-377M
-879.49%-382M
Depreciation and amortization
-58.22%4.01B
-48.03%977M
-61.00%1.01B
-61.06%1.01B
-60.03%1.01B
-1.64%9.6B
-23.70%1.88B
6.45%2.59B
6.74%2.6B
4.24%2.53B
Deferred tax
53.81%-965M
50.44%-392M
-40.23%-359M
-32.02%-437M
131.36%223M
36.47%-2.09B
40.39%-791M
21.71%-256M
69.52%-331M
-29.74%-711M
Other non cash items
-68.04%4.3B
171,500.00%1.72B
53.15%559M
1,319.38%1.83B
-98.47%198M
1,010.22%13.47B
-99.84%1M
4.58%365M
-11.03%129M
16,320.25%12.97B
Change In working capital
-156.17%-455M
-229.62%-1.65B
78.97%3.06B
100.63%15M
-1,044.95%-1.87B
142.32%810M
49.24%1.28B
486.60%1.71B
-39.47%-2.37B
114.56%198M
-Change in receivables
-211.74%-295M
-86.71%19M
-76.55%155M
52.50%-484M
-96.87%15M
126.53%264M
128.15%143M
367.61%661M
-1,467.69%-1.02B
373.71%479M
-Change in inventory
62.14%-184M
-59.43%71M
58.72%-90M
101.78%4M
22.48%-169M
35.29%-486M
188.83%175M
14.84%-218M
-1,306.25%-225M
22.70%-218M
-Change in payables and accrued expense
99.44%-6M
-164.89%-414M
245.01%1.05B
72.39%-608M
-102.56%-31M
-165.68%-1.08B
-57.12%638M
-6.18%-722M
3.59%-2.2B
12.98%1.21B
-Change in other working capital
-98.58%30M
-515.63%-1.33B
-2.17%1.94B
2.60%1.1B
-32.44%-1.69B
789.45%2.11B
344.44%320M
34.74%1.99B
61.65%1.08B
35.51%-1.27B
Cash from discontinued investing activities
Operating cash flow
-6.81%14.16B
-55.53%1.97B
12.88%6.31B
68.40%3.92B
-31.05%1.95B
9.60%15.19B
4.40%4.44B
17.68%5.59B
23.26%2.33B
-4.58%2.83B
Investing cash flow
Cash flow from continuing investing activities
80.65%-4.13B
-643.88%-1.46B
-677.17%-1.7B
64.14%-473M
97.46%-499M
-830.37%-21.35B
85.44%-196M
46.59%-219M
-300.91%-1.32B
-9,241.90%-19.62B
Capital expenditure reported
-5.05%-1.31B
2.12%-370M
1.23%-320M
-37.79%-361M
8.45%-260M
-3.23%-1.25B
-14.55%-378M
5.26%-324M
-1.16%-262M
-2.16%-284M
Net business purchase and sale
86.14%-2.87B
-599.30%-1.43B
-1,615.05%-1.6B
98.64%-15M
100.83%165M
-7,870.00%-20.72B
184.12%286M
-17.72%-93M
-11,130.00%-1.1B
-13,396.64%-19.81B
Net investment purchase and sale
-91.59%52M
426.92%340M
7.58%213M
-310.87%-97M
-184.52%-404M
174.82%618M
84.62%-104M
1,700.00%198M
157.50%46M
690.12%478M
Cash from discontinued investing activities
Investing cash flow
80.65%-4.13B
-643.88%-1.46B
-677.17%-1.7B
64.14%-473M
97.46%-499M
-830.37%-21.35B
85.44%-196M
46.59%-219M
-300.91%-1.32B
-9,241.90%-19.62B
Financing cash flow
Cash flow from continuing financing activities
-301.83%-10.35B
-267.17%-6.03B
61.32%-1.49B
54.36%-1.84B
-106.78%-993M
154.45%5.13B
-269.80%-1.64B
25.35%-3.85B
-85.14%-4.02B
580.13%14.64B
Net issuance payments of debt
-151.26%-5.18B
-1,068.89%-4.73B
91.55%-224M
79.11%-585M
-97.69%368M
2,114.04%10.1B
-119.27%-405M
-26,420.00%-2.65B
-2,158.06%-2.8B
1,155.09%15.95B
Net common stock issuance
--0
----
----
----
----
--0
--0
--0
----
----
Cash dividends paid
-3.74%-5.05B
-3.61%-1.26B
-3.87%-1.26B
-3.70%-1.26B
-3.80%-1.26B
-2.51%-4.86B
-5.00%-1.22B
-2.10%-1.22B
-1.67%-1.22B
-1.34%-1.21B
Proceeds from stock option exercised by employees
-20.75%-128M
-73.68%-33M
-118.75%-3M
283.33%11M
-6.19%-103M
-492.59%-106M
-176.00%-19M
-60.98%16M
-111.32%-6M
-5.43%-97M
Cash from discontinued financing activities
Financing cash flow
-301.83%-10.35B
-267.17%-6.03B
61.32%-1.49B
54.36%-1.84B
-106.78%-993M
154.45%5.13B
-269.80%-1.64B
25.35%-3.85B
-85.14%-4.02B
580.13%14.64B
Net cash flow
Beginning cash position
-10.17%10.35B
99.24%15.73B
100.30%12.61B
16.51%10.88B
-10.17%10.35B
23.53%11.52B
4.29%7.89B
-25.27%6.3B
3.16%9.33B
23.53%11.52B
Current changes in cash
68.70%-324M
-311.96%-5.51B
105.20%3.12B
153.32%1.61B
121.59%462M
-148.16%-1.04B
-32.84%2.6B
285.59%1.52B
-390.41%-3.02B
-637.93%-2.14B
Effect of exchange rate changes
242.34%195M
103.40%5M
-105.19%-4M
681.82%128M
246.67%66M
-404.44%-137M
-288.46%-147M
302.63%77M
-175.00%-22M
-446.15%-45M
End cash Position
-1.25%10.22B
-1.25%10.22B
99.24%15.73B
100.30%12.61B
16.51%10.88B
-10.17%10.35B
-10.17%10.35B
4.29%7.89B
-25.27%6.3B
3.16%9.33B
Free cash flow
-7.87%12.85B
-60.50%1.6B
13.75%5.99B
72.29%3.56B
-33.57%1.69B
10.20%13.94B
3.54%4.06B
19.46%5.27B
26.78%2.06B
-5.27%2.55B
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -6.81%14.16B-55.53%1.97B12.88%6.31B68.40%3.92B-31.05%1.95B9.60%15.19B4.40%4.44B17.68%5.59B23.26%2.33B-4.58%2.83B
Net income from continuing operations 178.98%7.06B1,327.63%1.09B80.66%2.2B-22.03%1.31B120.68%2.46B-211.11%-8.93B-95.69%76M-37.18%1.22B-18.92%1.68B-625.28%-11.91B
Operating gains losses -27.31%-1.45B-525.00%-475M-61.67%-485M28.12%-271M43.98%-214M-56.77%-1.14B74.50%-76M-35.14%-300M-128.48%-377M-879.49%-382M
Depreciation and amortization -58.22%4.01B-48.03%977M-61.00%1.01B-61.06%1.01B-60.03%1.01B-1.64%9.6B-23.70%1.88B6.45%2.59B6.74%2.6B4.24%2.53B
Deferred tax 53.81%-965M50.44%-392M-40.23%-359M-32.02%-437M131.36%223M36.47%-2.09B40.39%-791M21.71%-256M69.52%-331M-29.74%-711M
Other non cash items -68.04%4.3B171,500.00%1.72B53.15%559M1,319.38%1.83B-98.47%198M1,010.22%13.47B-99.84%1M4.58%365M-11.03%129M16,320.25%12.97B
Change In working capital -156.17%-455M-229.62%-1.65B78.97%3.06B100.63%15M-1,044.95%-1.87B142.32%810M49.24%1.28B486.60%1.71B-39.47%-2.37B114.56%198M
-Change in receivables -211.74%-295M-86.71%19M-76.55%155M52.50%-484M-96.87%15M126.53%264M128.15%143M367.61%661M-1,467.69%-1.02B373.71%479M
-Change in inventory 62.14%-184M-59.43%71M58.72%-90M101.78%4M22.48%-169M35.29%-486M188.83%175M14.84%-218M-1,306.25%-225M22.70%-218M
-Change in payables and accrued expense 99.44%-6M-164.89%-414M245.01%1.05B72.39%-608M-102.56%-31M-165.68%-1.08B-57.12%638M-6.18%-722M3.59%-2.2B12.98%1.21B
-Change in other working capital -98.58%30M-515.63%-1.33B-2.17%1.94B2.60%1.1B-32.44%-1.69B789.45%2.11B344.44%320M34.74%1.99B61.65%1.08B35.51%-1.27B
Cash from discontinued investing activities
Operating cash flow -6.81%14.16B-55.53%1.97B12.88%6.31B68.40%3.92B-31.05%1.95B9.60%15.19B4.40%4.44B17.68%5.59B23.26%2.33B-4.58%2.83B
Investing cash flow
Cash flow from continuing investing activities 80.65%-4.13B-643.88%-1.46B-677.17%-1.7B64.14%-473M97.46%-499M-830.37%-21.35B85.44%-196M46.59%-219M-300.91%-1.32B-9,241.90%-19.62B
Capital expenditure reported -5.05%-1.31B2.12%-370M1.23%-320M-37.79%-361M8.45%-260M-3.23%-1.25B-14.55%-378M5.26%-324M-1.16%-262M-2.16%-284M
Net business purchase and sale 86.14%-2.87B-599.30%-1.43B-1,615.05%-1.6B98.64%-15M100.83%165M-7,870.00%-20.72B184.12%286M-17.72%-93M-11,130.00%-1.1B-13,396.64%-19.81B
Net investment purchase and sale -91.59%52M426.92%340M7.58%213M-310.87%-97M-184.52%-404M174.82%618M84.62%-104M1,700.00%198M157.50%46M690.12%478M
Cash from discontinued investing activities
Investing cash flow 80.65%-4.13B-643.88%-1.46B-677.17%-1.7B64.14%-473M97.46%-499M-830.37%-21.35B85.44%-196M46.59%-219M-300.91%-1.32B-9,241.90%-19.62B
Financing cash flow
Cash flow from continuing financing activities -301.83%-10.35B-267.17%-6.03B61.32%-1.49B54.36%-1.84B-106.78%-993M154.45%5.13B-269.80%-1.64B25.35%-3.85B-85.14%-4.02B580.13%14.64B
Net issuance payments of debt -151.26%-5.18B-1,068.89%-4.73B91.55%-224M79.11%-585M-97.69%368M2,114.04%10.1B-119.27%-405M-26,420.00%-2.65B-2,158.06%-2.8B1,155.09%15.95B
Net common stock issuance --0------------------0--0--0--------
Cash dividends paid -3.74%-5.05B-3.61%-1.26B-3.87%-1.26B-3.70%-1.26B-3.80%-1.26B-2.51%-4.86B-5.00%-1.22B-2.10%-1.22B-1.67%-1.22B-1.34%-1.21B
Proceeds from stock option exercised by employees -20.75%-128M-73.68%-33M-118.75%-3M283.33%11M-6.19%-103M-492.59%-106M-176.00%-19M-60.98%16M-111.32%-6M-5.43%-97M
Cash from discontinued financing activities
Financing cash flow -301.83%-10.35B-267.17%-6.03B61.32%-1.49B54.36%-1.84B-106.78%-993M154.45%5.13B-269.80%-1.64B25.35%-3.85B-85.14%-4.02B580.13%14.64B
Net cash flow
Beginning cash position -10.17%10.35B99.24%15.73B100.30%12.61B16.51%10.88B-10.17%10.35B23.53%11.52B4.29%7.89B-25.27%6.3B3.16%9.33B23.53%11.52B
Current changes in cash 68.70%-324M-311.96%-5.51B105.20%3.12B153.32%1.61B121.59%462M-148.16%-1.04B-32.84%2.6B285.59%1.52B-390.41%-3.02B-637.93%-2.14B
Effect of exchange rate changes 242.34%195M103.40%5M-105.19%-4M681.82%128M246.67%66M-404.44%-137M-288.46%-147M302.63%77M-175.00%-22M-446.15%-45M
End cash Position -1.25%10.22B-1.25%10.22B99.24%15.73B100.30%12.61B16.51%10.88B-10.17%10.35B-10.17%10.35B4.29%7.89B-25.27%6.3B3.16%9.33B
Free cash flow -7.87%12.85B-60.50%1.6B13.75%5.99B72.29%3.56B-33.57%1.69B10.20%13.94B3.54%4.06B19.46%5.27B26.78%2.06B-5.27%2.55B
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
New progress emerged in Middle East peace talks on April 29, with Iran expected to submit a revised peace proposal soon. The previous three- Show More